Clinical Trials Sponsored by Ira Fox

Total 18487 results

The Cleveland Clinic
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Utilizing Neural Signatures and Virtual Reality to Advance DBS Programming

Parkinson Disease | Virtual Reality | Freezing of Gait | Deep Brain Stimulation | DBS

United States
University of Iowa
Michael J. Fox Foundation for Parkinson's Research

Active, not recruiting

Target Engagement of Terazosin in Healthy Adults

Healthy

United States
Spaulding Rehabilitation Hospital
Michael J. Fox Foundation for Parkinson's Research

Terminated

EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

Parkinson

United States
NYU Langone Health
Michael J. Fox Foundation for Parkinson's Research

Completed

Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

Parkinson Disease | Multiple System Atrophy | REM Sleep Behavior Disorder | Pure Autonomic Failure | Dementia With Lewy Bodies

United States
University of Washington
Michael J. Fox Foundation for Parkinson's Research

Unknown

Measures of Mitochondria Dysfunction in PD

Parkinson Disease, Mitochondrial

United States
University of Rochester
Michael J. Fox Foundation for Parkinson's Research

Completed

Buspirone in Parkinson's Disease

Parkinson Disease | Anxiety

United States
Impax Laboratories, LLC
Michael J. Fox Foundation for Parkinson's Research

Completed

Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study

Parkinson's Disease

United States
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Biomarkers in Neural Disorders

Parkinson's Disease | Myasthenia Gravis | Spinal Cord Injuries | Multiple System Atrophy | Progressive Supranuclear Palsy | Essential Tremor | Alzheimer's Disease | Diffuse Lewy Body Disease | Drug Induced Parkinson's Disease

United States
University of Michigan
Michael J. Fox Foundation for Parkinson's Research

Completed

Cholinergic Nicotinic Receptors and Cognition in PD (CHONI)

Parkinson's Disease

United States
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research

Completed

A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease

Parkinson's Disease | Mild Cognitive Impairment

United States
University of Washington
Michael J. Fox Foundation for Parkinson's Research

Completed

CNS Uptake of Intranasal Glutathione

Parkinson's Disease

United States
University of Florida
Michael J. Fox Foundation for Parkinson's Research

Completed

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Apathy in Parkinson's Disease (ReStore)

Parkinson's Disease

United States
Ken Marek, MD
Institute for Neurodegenerative Disorders

Completed

Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression (PPMI)

Parkinson Disease

United States, Spain, Israel, Norway, Germany, Italy, United Kingdom, France, Austria, Australia, Greece
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research

Completed

Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Parkinson Disease

United States
The Cleveland Clinic
Michael J. Fox Foundation for Parkinson's Research

Completed

Dual-task Augmented Reality Treatment for Parkinson's Disease (DART)

Parkinson Disease

United States
Virginia Commonwealth University
Michael J. Fox Foundation for Parkinson's Research

Withdrawn

Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

Parkinson Disease

United States
University Hospital Tuebingen
Michael J. Fox Foundation for Parkinson's Research

Unknown

Combined Stimulation of STN and SNr for Dysphagia in Parkinson's Disease

Parkinson's Disease | Dysphagia

Germany
NeuroHealing Pharmaceuticals Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients

Sialorrhea (Excessive Drooling)

France
University of Pennsylvania
Michael J. Fox Foundation for Parkinson's Research

Completed

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Parkinson Disease | Impulse Control Disorder

United States
University of Cincinnati
Michael J. Fox Foundation for Parkinson's Research

Completed

Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease

Parkinson's Disease | Gait Impairment

United States
Salena Killion
Michael J. Fox Foundation for Parkinson's Research

Unknown

Using Heavy Water to Study Cell Dynamics in Parkinson's Disease

HIV Infections | Parkinson's Disease

United States
University of Toronto
Michael J. Fox Foundation for Parkinson's Research

Unknown

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Parkinson's Disease

Canada
University of Michigan
Michael J. Fox Foundation for Parkinson's Research

Completed

Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease

Parkinson's Disease

United States
Xuanwu Hospital, Beijing
Michael J. Fox Foundation for Parkinson's Research

Completed

LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers

Parkinson Disease

China
University of Chicago
Michael J. Fox Foundation for Parkinson's Research

Completed

Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS

Parkinson's Disease

United States
Motus Therapeutics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation (MOVE-PD)

Parkinson's Disease

United States
NeuroHealing Pharmaceuticals Inc.
Michael J. Fox Foundation for Parkinson's Research

Completed

Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients (NH004-2)

Sialorrhea Secondary to Parkinson's Disease

Argentina
Molecular Biometrics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Unknown

Spectroscopy in Parkinson Disease (SPIN-PD)

Parkinson Disease

United States
University Medical Center Groningen
PRA Health Sciences; TRACER Europe BV

Recruiting

Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study) (ACT-BOOSTER)

COVID-19

Netherlands
Sebela Women's Health Inc.
PRA Health Sciences

Not yet recruiting

Evaluation of the Efficacy, Safety, and Tolerability of LevoCept

Contraception | Women at Risk for Pregnancy

United States
Tetraphase Pharmaceuticals, Inc.
PRA Health Sciences

Completed

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

Healthy Subjects

United Kingdom
Sleep Systems
New England IRB; Mass Lung and Allergy, PC

Completed

Apnea Hypopnea Index Severity Versus Head Position During Sleep

Sleep Apnea, Obstructive | Snoring | Sleep Apnea | Sleep Disordered Breathing | Sleep Hypopnea

United States
University Medical Center Groningen
ISA Pharmaceuticals B.V.; Dutch Cancer Society

Completed

p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer (ISA-P53-CTX)

Ovarian Cancer

Netherlands
Rosenfeld, William E., M.D.
UCB Biopharma S.P.R.L.; PRA Health Sciences; Utrecht University; Comprehensive...

Completed

Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint

Photosensitive Epilepsy

United States
DR. DIANE CHISESI NFS. MD. PHD.
IRB

Not yet recruiting

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor (NASBP-B-09)

Chronic Pain | Metastatic Breast Cancer | Tumor | Muscle Neoplasms

United States
Kalyra Pharmaceuticals, Inc.
United States Department of Defense; PRA Health Sciences

Terminated

A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

Analgesia

United States
Dra. Olga Graciela Cantu Rodriguez

Completed

Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Mexico
Johns Hopkins Bloomberg School of Public Health
United States Agency for International Development (USAID); Ministry of Health... and other collaborators

Completed

Study of Effectiveness of Mental Health Interventions Among Torture Survivors in Southern Iraq

Depression | Anxiety | Post-Traumatic Stress Disorder

Iraq
Iva Hauptmannova
International Spinal Research Trust

Recruiting

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Spinal Cord Injuries

United Kingdom
Dr Irma Bernadette S Sitohang

Completed

Oral Glutathione As A Skin Whitening Agent

Glutathione | Skin Whitening

Indonesia
AstraZeneca
RTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)

Completed

OSCA - Olaparib Standard of CAre Study (OSCA)

Platinum-sensitive Recurrent Serous Ovarian Cancer

France, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
Bayer
Dra. Pilar Escribano Subías - Coordinator - HU 12 de Octubre - Madrid (Spain)

Completed

Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System (Inventa)

Pulmonary Arterial Hypertension

Spain
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Validation of Dyskinesia Rating Scales

Parkinson's Disease

United States, Austria, Canada, France
Maastricht University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Cognitive Behavioural Therapy for Anxiety Disorders in PD

Parkinson's Disease | Generalized Anxiety Disorder | Social Phobia

France, Netherlands
University of Florida
Medtronic; Michael J. Fox Foundation for Parkinson's Research

Completed

A Responsive Closed-Loop Approach to Treat Freezing of Gait in Parkinson's Disease

Parkinsons Disease

United States
Rush University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Improve Speech Using an In-the-ear Device in Parkinson's Disease (MJFFSpeech)

Parkinson's Disease | Dysarthria

United States
University Hospital Schleswig-Holstein
Michael J. Fox Foundation for Parkinson's Research

Recruiting

Sensorimotor Integration in Monogenic Parkinson-dystonia Syndromes (SensoMo-PD)

Dystonia | Parkinson | Dystonia, Familial | DYT3 | DYT5 | PINK1 Gene Deletion

Germany
Northwestern University
Michael J. Fox Foundation for Parkinson's Research; Koneksa Health

Recruiting

A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease (Voice-PD)

Parkinson Disease

United States
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease (TALISMAN)

Parkinson Disease | Effect of Drug

Netherlands
Radboud University Medical Center
Michael J. Fox Foundation for Parkinson's Research

Completed

PERsonalized SPEeCh Therapy for actIVE Conversation (PERSPECTIVE)

Parkinson Disease

Netherlands

Clinical Trials Sponsored by Ira Fox

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations